People with a lung scarring condition that leaves them fighting for breath could be helped by a new medication, research suggests. Results from an early stage clinical trial show that the new drug has no serious side effects and was well tolerated by patients with the condition, called Idiopathic Pulmonary Fibrosis. New therapy The findings...